Urinary neurotrophic factors in healthy individuals and patients with overactive bladder

Journal of Urology

Volumn 189, Issue 1, 2013, Pages 359-365

  Antunes Lopes, Tiago ^a,b,c   Pinto, Rui ^a,b,c   Barros, Sérgio C ^a,c   Botelho, Francisco ^a,b   Silva, Carlos M ^a,b,c   Cruz, Célia D ^a,c   Cruz, Francisco ^a,b,c  

^a UNIVERSITY OF PORTO   (Portugal)

^b University of Porto   (Portugal)

^c UNIVERSITY OF PORTO   (Portugal)

Author keywords

brain derived neurotrophic factor; glial cell line derived neurotrophic factor; muscarinic antagonists; nerve growth factors; urinary bladder overactive

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CREATININE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NERVE GROWTH FACTOR; OXYBUTYNIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; LIFESTYLE MODIFICATION; MALE; OVERACTIVE BLADDER; PRIORITY JOURNAL; RATING SCALE; TREATMENT DURATION; URINALYSIS; URINARY URGENCY;

ADULT; BRAIN-DERIVED NEUROTROPHIC FACTOR; FEMALE; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; HUMANS; MALE; MIDDLE AGED; NERVE GROWTH FACTOR; REFERENCE VALUES; URINARY BLADDER, OVERACTIVE; YOUNG ADULT;

EID: 84870862035     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2012.08.187     Document Type: Article

References (29)

1. P. Ochodnický, C.D. Cruz, N. Yoshimura Nerve growth factor in bladder dysfunction: contributing factor, biomarker, and therapeutic target Neurourol Urodyn 30 2011 1227
2. E. Murray, S.E. Malley, L.Y. Qiao Cyclophosphamide induced cystitis alters neurotrophin and receptor tyrosine kinase expression in pelvic ganglia and bladder J Urol 172 2004 2434
3. L.Y. Qiao, M.A. Vizzard Cystitis-induced upregulation of tyrosine kinase (TrkA, TrkB) receptor expression and phosphorylation in rat micturition pathways J Comp Neurol 454 2002 200
4. H. Sariola, M. Saarma Novel functions and signalling pathways for GDNF J Cell Sci 116 2003 3855
5. E.M. Lowe, P. Anand, G. Terenghi Increased nerve growth factor levels in the urinary bladder of women with idiopathic sensory urgency and interstitial cystitis Br J Urol 79 1997 572
6. R. Pinto, B. Frias, S. Allen Sequestration of brain-derived nerve factor by intravenous delivery of TrkB-Ig2 reduces bladder overactivity and noxious input in animals with chronic cystitis Neuroscience 166 2010 907
7. H.T. Liu, H.C. Kuo Urinary nerve growth factor level could be a potential biomarker for diagnosis of overactive bladder J Urol 179 2008 2270
8. T. Antunes-Lopes, S. Carvalho-Barros, C.D. Cruz Biomarkers in overactive bladder: a new objective and noninvasive tool? Adv Urol 2011 2011 382431
9. H.T. Liu, C.Y. Chen, H.C. Kuo Urinary nerve growth factor in women with overactive bladder syndrome BJU Int 107 2011 799
10. H.C. Kuo, H.T. Liu, M.B. Chancellor Can urinary nerve growth factor be a biomarker for overactive bladder? Rev Urol 12 2010 e69
11. H.T. Liu, M.B. Chancellor, H.C. Kuo Decrease of urinary nerve growth factor levels after antimuscarinic therapy in patients with overactive bladder BJU Int 103 2009 1668
12. H.T. Liu, M.B. Chancellor, H.C. Kuo Urinary nerve growth factor levels are elevated in patients with detrusor overactivity and decreased in responders to detrusor botulinum toxin-A injection Eur Urol 56 2009 700
13. T. Antunes-Lopes, R. Pinto, S. Carvalho-Barros Urinary levels of Brain Derived Neurotrophic Factor (BDNF) in women with overactive bladder (OAB) syndrome correlate with the severity of symptoms Eur Urol 10 Suppl 2011 277
14. A. Nixon, S. Colman, L. Sabounjian A validated patient reported measure of urinary urgency severity in overactive bladder for use in clinical trials J Urol 174 2005 604
15. K. Lamb, G.F. Gebhart, K. Bielefeldt Increased nerve growth factor expression triggers bladder overactivity J Pain 5 2004 150
16. V.Y. Hu, P. Zvara, A. Dattilio Decrease in bladder overactivity with REN1820 in rats with cyclophosphamide induced cystitis J Urol 173 2005 1016
17. R.J. Evans, R.M. Moldwin, N. Cossons Proof of concept trial of tanezumab for the treatment of symptoms associated with interstitial cystitis J Urol 185 2011 1716
18. A. Avelino, F. Cruz TRPV1 (vanilloid receptor) in the urinary tract: expression, function and clinical applications Naunyn Schmiedebergs Arch Pharmacol 373 2006 287
19. C. Silva, M.J. Ribeiro, F. Cruz The effect of intravesical resiniferatoxin in patients with idiopathic detrusor instability suggests that involuntary detrusor contractions are triggered by C-fiber input J Urol 168 2002 575
20. L.A. Birder, W.C. de Groat Mechanisms of disease: involvement of the urothelium in bladder dysfunction Nat Clin Pract Urol 4 2007 46
21. D.B. Clemow, W.D. Steers, J.B. Tuttle Stretch-activated signaling of nerve growth factor secretion in bladder and vascular smooth muscle cells from hypertensive and hyperactive rats J Cell Physiol 183 2000 289
22. W.D. Steers, S. Kolbeck, D. Creedon Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function J Clin Invest 88 1991 1709
23. H.T. Liu, H. Lin, H.C. Kuo Increased serum nerve growth factor levels in patients with overactive bladder syndrome refractory to antimuscarinic therapy Neurourol Urodyn 30 2011 1525
24. E. Castrén, T. Rantamäki Role of brain-derived neurotrophic factor in the aetiology of depression: implications for pharmacological treatment CNS Drugs 24 2010 1
25. Y.B. Yu, X.L. Zuo, Q.J. Zhao Brain-derived neurotrophic factor contributes to abdominal pain in irritable bowel syndrome Gut 61 2012 685
26. K.E. Andersson Antimuscarinic mechanisms and the overactive detrusor: an update Eur Urol 59 2010 377
27. P. Abrams, L. Cardozo, M. Fall The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society Neurourol Urodyn 21 2002 167
28. R. Pinto, T. Lopes, B. Frias Trigonal injection of botulinum toxin A in patients with refractory bladder pain syndrome/interstitial cystitis Eur Urol 58 2010 360
29. H.C. Kuo, H.T. Liu, P. Tyagi Urinary nerve growth factor levels in urinary tract diseases with or without frequency urgency symptoms LUTS 2 2010 88